EU Regulatory Round-Up: RWE Platform Proposed, Brexit Transition Update, EPI Principles Published
Executive Summary
The latest EU regulatory developments - EMA and HMA are looking to build an EU-wide real-world data platform; EU OTC firms can operate as normal in the UK until the end of the year; EMA, HMA and the EC have published key principles on how to develop and use electronic product information for medicines marketed within the EU.
You may also be interested in...
EU Regulatory News Round Up: NSAIDs During Pregnancy, Estragole Excipients, ePIs
CMDh receives applications to change how NSAIDs are recommended for use during pregnancy; HMPC warns against use of estragole-containing excipients in herbals; EMA adopts new EU common standard for electronic product information on medicines marketed within the region.
Learn From Regulatory Innovation During COVID-19, Urges Global Self-Care Industry
The Global Self-Care Federation has published three papers outlining how regulatory flexibility and innovation seen during the cornavirus pandemic can be brought forward to a post-pandemic consmer heathcare sector.
Real-World Data One Of Five Areas For Improvement For EU Digital Self-Care Regulation
The AESGP in a new position paper calls for a flexible regulatory framework to unlock the "tremendous opportunity" of digital innovation in self-care.